J-Y. Lee

718 total citations
27 papers, 447 citations indexed

About

J-Y. Lee is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J-Y. Lee has authored 27 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J-Y. Lee's work include Cancer Immunotherapy and Biomarkers (4 papers), HER2/EGFR in Cancer Research (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). J-Y. Lee is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), HER2/EGFR in Cancer Research (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). J-Y. Lee collaborates with scholars based in South Korea, United States and Spain. J-Y. Lee's co-authors include Gu Kong, Yibin Kang, Hyung Jun Kim, Tingting Qian, SH Lee, Cheol‐Hee Kim, Yong Kim, Yun Sang Cho, Hyun‐Seok Jin and Bermseok Oh and has published in prestigious journals such as Cancer Research, Oncogene and Annals of Oncology.

In The Last Decade

J-Y. Lee

23 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J-Y. Lee South Korea 12 247 102 98 40 37 27 447
Christina Nadolny United States 11 146 0.6× 86 0.8× 109 1.1× 31 0.8× 38 1.0× 14 344
Tianhe Li China 9 136 0.6× 43 0.4× 63 0.6× 43 1.1× 56 1.5× 22 338
Kasey R. Cargill United States 9 182 0.7× 52 0.5× 80 0.8× 65 1.6× 40 1.1× 13 356
Natasha P. Clayton United States 13 158 0.6× 82 0.8× 69 0.7× 20 0.5× 17 0.5× 29 510
Vinay Singh Tanwar India 13 307 1.2× 129 1.3× 27 0.3× 25 0.6× 50 1.4× 22 502
Sayed Mostafa Hosseini Iran 10 142 0.6× 104 1.0× 106 1.1× 34 0.8× 15 0.4× 29 336
Yi Cheng China 13 410 1.7× 220 2.2× 109 1.1× 40 1.0× 16 0.4× 30 637
Abulizi Abudula China 13 262 1.1× 149 1.5× 95 1.0× 101 2.5× 15 0.4× 31 462
Tamio Fukushima Japan 13 171 0.7× 107 1.0× 73 0.7× 28 0.7× 20 0.5× 29 451

Countries citing papers authored by J-Y. Lee

Since Specialization
Citations

This map shows the geographic impact of J-Y. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J-Y. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J-Y. Lee more than expected).

Fields of papers citing papers by J-Y. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J-Y. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J-Y. Lee. The network helps show where J-Y. Lee may publish in the future.

Co-authorship network of co-authors of J-Y. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of J-Y. Lee. A scholar is included among the top collaborators of J-Y. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J-Y. Lee. J-Y. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, J-Y., Funda Meric‐Bernstam, Ana Oaknin, et al.. (2025). 145P Trastuzumab deruxtecan (T-DXd) in pretreated patients (pts) with HER2-expressing solid tumors: Exploratory biomarker analysis of DESTINY-PanTumor02 (DP-02) Part 1. Annals of Oncology. 36. S251–S252. 1 indexed citations
3.
Lee, Yu Jin, et al.. (2024). 765P HER2 expression in ovarian cancer: Its relationship with HRD status, and other biomarkers. Annals of Oncology. 35. S579–S579. 2 indexed citations
4.
5.
Meric‐Bernstam, Funda, Vicky Makker, Ana Oaknin, et al.. (2023). LBA34 Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2-expressing solid tumors: Primary analysis from the DESTINY-PanTumor02 (DP-02) study. Annals of Oncology. 34. S1273–S1274. 3 indexed citations
6.
Lorusso, Domenica, Yang Xiang, Giovanni Scambia, et al.. (2023). LBA38 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study. Annals of Oncology. 34. S1279–S1280. 24 indexed citations
7.
Vergote, Ignace, Antonio González-Martı́n, Keiichi Fujiwara, et al.. (2023). LBA9 innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer. Annals of Oncology. 34. S1276–S1277. 24 indexed citations
8.
Cho, Byoung Chul, Jia-Lin Lee, Byoung Yong Shim, et al.. (2023). 1027P An open-label, multicenter, phase I/II study of GI-101, CD80-IgG4 Fc-IL2v, in advanced solid tumors (Part A of GII-101-P101; KEYNOTE-B59). Annals of Oncology. 34. S624–S625. 2 indexed citations
9.
10.
Lee, J-Y., et al.. (2022). 588P Prognostic value of circulating tumor DNA (ctDNA) in ovarian cancer. Annals of Oncology. 33. S815–S815. 1 indexed citations
11.
12.
Jung, Jiwon, J-Y. Lee, Seungho Ryu, et al.. (2019). Outbreak of carbapenemase-producing Enterobacteriaceae associated with a contaminated water dispenser and sink drains in the cardiology units of a Korean hospital. Journal of Hospital Infection. 104(4). 476–483. 29 indexed citations
13.
Kim, Gyuri, Yong‐ho Lee, J-Y. Lee, et al.. (2017). Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice. International Journal of Obesity. 42(3). 542–551. 16 indexed citations
14.
Cerella, Claudia, Anthoula Gaigneaux, Aloran Mazumder, et al.. (2016). Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia. Leukemia. 31(3). 755–759. 21 indexed citations
15.
Lee, SH, et al.. (2014). A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cells. Cell Death and Disease. 5(10). e1477–e1477. 18 indexed citations
16.
17.
Qian, Tingting, J-Y. Lee, Jin‐hong Park, Hyung Jun Kim, & Gu Kong. (2010). Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex. Oncogene. 29(43). 5818–5827. 15 indexed citations
18.
Hong, Kyung‐Won, Hyun‐Seok Jin, J-Y. Lee, et al.. (2009). Genetic variations in ATP2B1, CSK, ARSG and CSMD1 loci are related to blood pressure and/or hypertension in two Korean cohorts. Journal of Human Hypertension. 24(6). 367–372. 67 indexed citations
19.
Lee, J-Y., Tingting Qian, Hyung Jun Kim, et al.. (2008). Id-1 activates Akt-mediated Wnt signaling and p27Kip1 phosphorylation through PTEN inhibition. Oncogene. 28(6). 824–831. 55 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Nadolny Breakdown of academic impact, for papers by Tianhe Li Breakdown of academic impact, for papers by Kasey R. Cargill Breakdown of academic impact, for papers by Natasha P. Clayton Breakdown of academic impact, for papers by Vinay Singh Tanwar Breakdown of academic impact, for papers by Sayed Mostafa Hosseini Breakdown of academic impact, for papers by Yi Cheng Breakdown of academic impact, for papers by Abulizi Abudula Breakdown of academic impact, for papers by Tamio Fukushima
Rankless by CCL
2026